← Eichor
Study identifier: NCT05994170 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Reducing High Risk Primary Tumor Clinical Target Volumes (CTVp1) in Non-metastatic Nasopharyngeal Carcinoma

Condition: Nasopharyngeal Carcinoma · Intensity-Modulated Radiotherapy  ·  Sponsor: Zhongshan People's Hospital, Guangdong, China

PhaseNA
Planned participants454
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersNo

About this study

To evaluate the long-term local control, survival rate, acute and late radiation related toxicities, quality of life after reducing high risk primary tumor clinical target volumes (CTVp1) in non-metastatic nasopharyngeal carcinoma treated with IMRT.

This description comes directly from the study's public registry record.

Talk to the study team

Gui-qiong Xu  ·  +8613528109888  ·  donna_shee@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Zhongshan City People's HospitalZhongshan, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05994170